Antitumor necrosis factor, infliximab, and adalimumab: use with caution in eosinophilic bowel disease

J Pediatr Gastroenterol Nutr. 2013 Oct;57(4):e25. doi: 10.1097/MPG.0b013e3182a1e13b.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Enterocolitis / drug therapy*
  • Eosinophilia / drug therapy*
  • Female
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*
  • Male
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Tumor Necrosis Factor-alpha